title: Is EPO therapy able to correct iron deficiency anaemia caused by matriptase-2 deficiency?
authors.forename: Gaël
authors.initials: G
authors.lastname: Nicolas
authors.forename: Jean-Christophe
authors.initials: JC
authors.lastname: Deschemin
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Ramsay
authors.forename: Patrick
authors.initials: P
authors.lastname: Mayeux
authors.forename: Bernard
authors.initials: B
authors.lastname: Grandchamp
authors.forename: Carole
authors.initials: C
authors.lastname: Beaumont
authors.forename: Gloria
authors.initials: G
authors.lastname: Velasco
authors.forename: Sophie
authors.initials: S
authors.lastname: Vaulont
mesh_terms: D018798:Anemia, Iron-Deficiency / Q000188:drug therapy*; D000818:Animals; D004921:Erythropoietin / Q000627:therapeutic use*; D008565:Membrane Proteins / Q000172:deficiency*; D051379:Mice; D018345:Mice, Knockout; D011994:Recombinant Proteins; D012697:Serine Endopeptidases / Q000172:deficiency*
chemical_list: D008565:Membrane Proteins; D011994:Recombinant Proteins; D004921:Erythropoietin; D012697:Serine Endopeptidases; C467801:matriptase 2